drugset / Trial / NCT03677297

"Efficacy Of 1.2% Rosuvastatin Gel In The Management Of Infrabony Defects"

NCT03677297 ↗

Phase 4 Completed 10 enrolled Dr. D. Y. Patil Dental College & Hospital
RandomizedCrossoverDouble-blindTreatment

Summary

Study aims to evaluate clinical and radiographic effectiveness of 1.2% Rosuvastatin gel in the treatment of Infrabony defects in chronic periodontitis patients.

Timeline

Start
2016-01-28
Primary completion
2017-08-01
Completion
2017-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 1.2 % Other